AMERICAN AIRLINES GROUP INC (AAL)       16.96  +0.04 (+0.24%)

16.96  +0.04 (+0.24%)

US02376R1023 - Common Stock - After market: 16.98 +0.02 (+0.12%)


Fundamental Rating

3

Taking everything into account, AAL scores 3 out of 10 in our fundamental rating. AAL was compared to 34 industry peers in the Airlines industry. AAL has a bad profitability rating. Also its financial health evaluation is rather negative. AAL is not valued too expensively and it also shows a decent growth rate.

Note: AAL has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

AAL has a Piotroski-F score of 6.00. This indicates an average health and profitability for AAL.

VS Industry

Valuation

Valuation Rating

5

The Forward Price/Earnings Ratio of 11.16 indicates a rather cheap valuation of AAL.
AAL's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

With a Price/Earnings Ratio of 56.53, AAL can be considered very expensive at the moment.
Compared to an average industry Price/Earning Ratio of 35.57, AAL is valued slightly more expensive.
VS Industry

Price/Earnings (56.53) VS Industry: 29% outperformed.

200.00
7.55

Growth

Growth Rating

6

The Earnings Per Share has grown by an impressive 103.56% over the past year.
AAL is expected to show a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 159.16% yearly.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Revenue has grown by 93.67% in the past year. This is a very strong growth!

Measured over the past 5 years, AAL shows a small growth in Revenue. The Revenue has been growing by 2.82% on average per year.
AAL is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 2.40% yearly.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
AAL shows a very negative growth in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -42.80% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-42.8% -60.61% 103.56% 406.76% 187.54% 159.16% N/A
Revenue2.82% 2.28% 93.67% 4.51% 4.34% 3.96% 2.4%

Health

Health Rating

1

AAL has a Current Ratio comparable to the industry average, which is at 0.93.
AAL has a Piotroski-F score of 6.00. This indicates an average health and profitability for AAL.
AAL has a Current Ratio of 0.71. This is a bad value and indicates that AAL is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.60 indicates that AAL may have some problems paying its short term obligations.

Compared to an average industry Quick Ratio of 0.93, AAL is worse placed to pay its short term obligations than its industry peers.
AAL has an Altman-Z score of 0.70. This is a bad value and indicates that AAL is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of AAL to the average industry Altman-Z score of 1.32, AAL is less financially healthy than its industry peers.
VS Industry

Quick Ratio (0.6) VS Industry: 35% outperformed.

0.17
38.33

Current Ratio (0.71) VS Industry: 41% outperformed.

0.23
38.33

Altman-Z (0.7) VS Industry: 34% outperformed.

-2.07
13.83

Dividend

Dividend Rating

0

AAL does not give a dividend.

AMERICAN AIRLINES GROUP INC16.96

NASDAQ:AAL (2/7/2023, 7:21:53 PM)+0.04 (+0.24%)

After market: 16.98 +0.02 (+0.12%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Transportation
GICS Industry Airlines
Earnings (Last) 01-26 2023-01-26/bmo Earnings (Next) 04-19 2023-04-19/amc
Inst Owners 56.58% Inst Owner Change -0.2%
Ins Owners 1.26% Ins Owner Change 2.18%
Market Cap 11.02B Analysts 54.81
Price Target 16.56 (-2.36%)

Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y) N/A DP 0%
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 11.47%
Min EPS beat(2) 1.24% Max EPS beat(2) 21.7%
EPS beat(4) 3 Avg EPS beat(4) 6.54%
Min EPS beat(4) -1.19% Max EPS beat(4) 21.7%
Revenue beat(2) N/A Avg Revenue beat(2) -0.86%
Min Revenue beat(2) -1.07% Max Revenue beat(2) -0.64%
Revenue beat(4) 1 Avg Revenue beat(4) 15.76%
Min Revenue beat(4) -1.07% Max Revenue beat(4) 64.94%
PT rev (1m) 4.28% PT rev (3m) 0.34%
EPS NQ rev (1m) 111.79% EPS NQ rev (3m) 107.4%
EPS NY rev (1m) 0% EPS NY rev (3m) 11.75%
Revenue NQ rev (1m) 4.58% Revenue NQ rev (3m) 4.03%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -0.29%

Valuation
Industry RankSector Rank
PE 56.53
Fwd PE 11.16
P/S 0.19
P/FCF N/A
P/OCF 5.07
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM) 0.3 EY 1.77%
EPS(NY) 1.52 Fwd EY 8.96%
FCF(TTM) -1.13 FCFY N/A
OCF(TTM) 3.34 OCFY 19.71%
SpS 89.05 BVpS -8.92
TBVpS -18.39 PEG (NY) 0.14
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 0.37%
ROICexc 0.47%
ROICexgc 0.58%
OM 0.41%
PM N/A
GM 57.23%
ROICexgc(3y) N/A ROICexcg growth 3Y -18.19%
ROICexcg growth 5Y -19.59% ROICexc(3y) N/A
ROICexc growth 3Y -18.73% ROICexc growth 5Y -19.29%
OM growth 3Y -23.15% OM growth 5Y -20.6%
PM growth 3Y -58.71% PM growth 5Y -38.75%
GM growth 3Y -1.95% GM growth 5Y -2.22%
F-Score 6 Asset Turnover 0.89

Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.6
Altman-Z 0.7
F-Score 6 WACC 6.13%
ROIC/WACC 0.09 Cap/Depr(3y) N/A
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 103.56% EPS 3Y -60.61%
EPS 5Y -42.8% EPS growth Q2Q 182.39%
EPS Next Y 406.76% EPS Next 2Y 187.54%
EPS Next 3Y 159.16% EPS Next 5Y N/A
Revenue growth 1Y 93.67% Revenue growth 3Y 2.28%
Revenue growth 5Y 2.82% Revenue growth Q2Q 39.91%
Revenue Next Year 4.51% Revenue Next 2Y 4.34%
Revenue Next 3Y 3.96% Revenue Next 5Y 2.4%
EBIT growth 1Y 104.47% EBIT growth 3Y -21.39%
EBIT growth 5Y -18.37% EBIT Next Year 280.7%
EBIT Next 3Y 89.98% EBIT Next 5Y N/A
FCF growth 1Y -351.03% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y 208.67%
OCF growth 3Y -17.11% OCF growth 5Y -14.46%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA